Pharming Group NV (PHARM) — Cash Flow Reinvestment Rate
Pharming Group NV (PHARM) has a Cash Flow Reinvestment Rate of 0.00x as of September 2025, reinvesting €93.00K (capex €70.00K plus investments €23.00K) from operating cash flow of €32.03 Million. Explore PHARM capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Pharming Group NV Cash Flow Reinvestment Rate (2017–2022)
Historical reinvestment intensity for Pharming Group NV across 6 annual periods. Also explore Pharming Group NV asset portfolio for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Pharming Group NV (2017–2022)
Year-by-year capital reinvestment analysis for Pharming Group NV. For live market cap and broader valuation context, see Pharming Group NV market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.41x | €9.28 Million | €22.90 Million | €1.98 Million | ▼ -28.8% |
| 2021 | 0.57x | €20.55 Million | €36.13 Million | €15.96 Million | ▲ +208.0% |
| 2020 | 0.18x | €16.80 Million | €90.98 Million | €16.47 Million | ▼ -51.3% |
| 2019 | 0.38x | €28.25 Million | €74.56 Million | €25.44 Million | ▲ +145.9% |
| 2018 | 0.15x | €7.12 Million | €46.19 Million | €4.31 Million | ▼ -27.6% |
| 2017 | 0.21x | €9.76 Million | €45.84 Million | €7.25 Million | — |